Search for stock quotes, financial statistics and more
Following some good news for the company, Roth MKM analyst Jonathan Aschoff has maintained his ̶... Read More
Roth Capital Partners analyst Johnathan Aschoff kept a “Buy” rating on biotech stock Panbela The... Read More
Share
Tweet
pin
Share